<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03652675</url>
  </required_header>
  <id_info>
    <org_study_id>7649</org_study_id>
    <secondary_id>K23AA023753</secondary_id>
    <nct_id>NCT03652675</nct_id>
  </id_info>
  <brief_title>Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV</brief_title>
  <official_title>Understanding and Intervening With Heavy Drinking Among Patients With HIV and HCV: Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York State Psychiatric Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Alcohol Abuse and Alcoholism (NIAAA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>New York State Psychiatric Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Among patients with HIV, especially those also infected with HCV, heavy drinking is&#xD;
      associated with significant risks to health. However, little is known about how to best&#xD;
      intervene with co-infected heavy drinkers, a particularly high risk group for whom targeted&#xD;
      intervention has not been developed. Therefore, this study proposes to test a newly developed&#xD;
      drinking-reduction intervention for patients with both HIV and HCV, which combines components&#xD;
      of successful interventions developed for HIV and for liver disease patients.&#xD;
&#xD;
      60 HIV/HCV co-infected drinkers from HIV primary care will be recruited in order to ensure an&#xD;
      adequate final sample size of 45 participants completing the study. A clinic recruiter will&#xD;
      identify and refer potential participants based on their medical record, who will then be&#xD;
      screened for eligibility by the research coordinator. Potential participants from outside of&#xD;
      this clinic will also be recruited through self-referrals via flyers and through RecruitMe,&#xD;
      an online based recruitment tool. Participants will be randomly assigned to an intervention&#xD;
      or control condition, while ensuring that equal numbers of individuals with alcohol use&#xD;
      disorder are assigned to each condition. The intervention condition will receive brief&#xD;
      in-person sessions with a counselor and will be asked to use a smartphone app daily to keep&#xD;
      track of drinking and other health behaviors for two months. The intervention sessions will&#xD;
      include information about HIV, HCV and alcohol, and the counselor will give the participant&#xD;
      information about their liver function and alcohol use to try to motivate them to drink less.&#xD;
      The control condition will simply be asked to drink less and will be given pamphlets with&#xD;
      general information on HIV, Hepatitis C, and drinking from educational websites on HIV/HCV&#xD;
      co-infection. The intervention condition will then be evaluated to see if it was more&#xD;
      effective at reducing drinking than the control condition.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with HIV have high rates of heavy drinking and alcohol problems, and face serious&#xD;
      medical consequences from this use. Some research suggests that alcohol can increase viral&#xD;
      load and decrease CD4 (cluster of differentiation 4; e.g., T helper cells) count, although&#xD;
      this literature is conflicting. It also increases risk for liver damage, as does hepatitis&#xD;
      co-infection, making liver disease a leading cause of death for patients with HIV. Patients&#xD;
      with alcohol problems are also less adherent to antiretroviral therapy (ART), and some&#xD;
      intentionally skip ART to try to avoid hepatotoxic effects of combining ART with alcohol.&#xD;
      Some studies also show alcohol's interference with other aspects of engagement in HIV care.&#xD;
&#xD;
      Approximately 25% of HIV-infected patients are co-infected with HCV. Although HCV alone can&#xD;
      lead to liver damage, HIV accelerates this progression, as does heavy drinking. Further,&#xD;
      individuals with HCV who drink heavily may be less likely to access HCV medication. Despite&#xD;
      serious health risks associated with alcohol use, some research suggests that HIV/HCV&#xD;
      patients drink more than HIV mono-infected patients.&#xD;
&#xD;
      Growing recognition of alcohol-related harm in HIV patients has stimulated the development of&#xD;
      drinking reduction interventions for HIV infected heavy drinkers, some of which have been&#xD;
      successful. Some interventions for HCV mono-infected drinkers and liver disease patients have&#xD;
      also shown promise. Yet there are no known successful interventions that target HIV/HCV&#xD;
      co-infected patients, a group with elevated drinking and particularly high consequences of&#xD;
      drinking. Interventions for HIV patients address HIV health, but do not address liver&#xD;
      fibrosis, which is an urgent threat to survival for co-infected patients. Interventions for&#xD;
      liver disease patients discuss fibrosis to motivate drinking reduction, but neglect HIV and&#xD;
      important topics such as ART adherence. Given that the drinking interventions for HIV and&#xD;
      liver disease patients both effectively target drinking in medical patients, albeit through&#xD;
      attention to different medical issues, such approaches can and should be integrated to&#xD;
      provide an intervention that best meets the needs of patients with both HIV and HCV, a&#xD;
      particularly high-risk group. In order to meet this need, an intervention will be tested for&#xD;
      HIV/HCV co-infected drinkers. A total of 60 patients will be recruited and randomized to&#xD;
      receive either the newly developed intervention or an educational control.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 1, 2018</start_date>
  <completion_date type="Actual">June 8, 2020</completion_date>
  <primary_completion_date type="Actual">June 8, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>After participants complete the screening assessment, the research coordinator will be able to determine alcohol use disorder status from the responses. The research coordinator will provide the counselor or PI with subject identification number (ID; assigned consecutively) and alcohol use disorder status. The counselor or PI will then randomize participants using pre-determined blocked lists created by a biostatistician, in order to balance treatment groups across alcohol use disorder status (the research coordinator will not randomize in order to remain blind to condition).</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Mean Drinks Per Drinking Day Measured Using Timeline Follow Back (TLFB) at 60 Days.</measure>
    <time_frame>60 days (end of treatment)</time_frame>
    <description>Mean drinks per drinking day in the last 30 days, assessed at baseline and repeatedly during follow-up so that change can be analyzed. Abstention is coded as zero.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Number of Days Drank as Assessed by Item From the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS)</measure>
    <time_frame>60 days (end of treatment)</time_frame>
    <description>Number of days drank in the last 30 days (RANGE 0-30) was assessed at baseline and repeatedly during follow-up so that change can be analyzed. A change value is calculated here such that a negative value indicates a decrease in drinking.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Largest Number of Drinks Assessed by Item From the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS)</measure>
    <time_frame>60 days (end of treatment)</time_frame>
    <description>The largest number of drinks consumed within one day in the last 30 days (RANGE 0-30) was assessed at baseline and repeatedly during follow-up so that change can be analyzed. A change value is calculated here such that a negative value indicates a decrease in drinking.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Number of Days Binge Drinking as Assessed by Item From the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS)</measure>
    <time_frame>60 days (end of treatment)</time_frame>
    <description>Number of days engaging in binge drinking (4+ drinks) in the last 30 days (RANGE 0-30) was assessed at baseline and repeatedly during follow-up so that change can be analyzed. A change value is calculated here such that a negative value indicates a decrease in drinking.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Number of Days Intoxicated as Assessed by Item From the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS)</measure>
    <time_frame>60 days (end of treatment)</time_frame>
    <description>Number of days intoxicated in the last 30 days (RANGE 0-30) was assessed at baseline and repeatedly during follow-up so that change can be analyzed. A change value is calculated here such that a negative value indicates a decrease in drinking.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Self-efficacy to Change Drinking as Measured by Brief Version of Situational Confidence Questionnaire (SCQ)</measure>
    <time_frame>60 days (end of treatment)</time_frame>
    <description>Self-efficacy to change drinking in the last 30 days, assessed at baseline and repeatedly during follow-up so that change can be analyzed. Participants rate eight situations regarding their confidence in their ability to resist drinking (0% - Not at all confident to 100% - Totally confident). The final score is an average that can range from 0 (lowest) to 100 (highest) self-efficacy.</description>
  </other_outcome>
  <other_outcome>
    <measure>Readiness to Change Drinking Measured by University of Rhode Island Change Assessment Scale (URICA)</measure>
    <time_frame>60 days (end of treatment)</time_frame>
    <description>Readiness to change drinking in the last 30 days, assessed at baseline and repeatedly during follow-up so that change can be analyzed.&#xD;
Higher scores indicate more readiness to change. Range from -2 to +14.&#xD;
The scale is scored when points are averaged for all four (precontemplation, contemplation, action, maintenance) scales. Add Contemplation + Action + Maintenance averages, then subtract Precontemplation average.</description>
  </other_outcome>
  <other_outcome>
    <measure>Readiness to Change Drinking Measured by The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES)</measure>
    <time_frame>60 days (end of treatment)</time_frame>
    <description>Readiness to change drinking in the last 30 days,assessed at baseline and repeatedly during follow-up so that change can be analyzed.&#xD;
Higher scores indicate more recognition, ambivalence, and taking steps toward change, respectively. For full range and interpretation, see individual outcomes below.&#xD;
Recognition scale - Range 7 (very low recognition) to 35 (high recognition)&#xD;
Ambivalence scale - Range 4 (very low ambivalence) to 20 (very high ambivalence)&#xD;
Taking Steps scale - Range 8 (very low on taking steps to change drinking) to 40 (very high score)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Alcohol Use Disorder</condition>
  <condition>HIV/AIDS</condition>
  <condition>Hepatitis C</condition>
  <condition>Binge Drinking</condition>
  <arm_group>
    <arm_group_label>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Educational control condition</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Participant will spend 20 minutes at the clinic, observed by the counselor, reviewing an educational pamphlet on drinking, HIV, and HCV.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</intervention_name>
    <description>This intervention consists of an adaptation of the National Institutes of Health (NIH) Clinician's Guide (CG; NIAAA, 2007) in conjunction with the previously tested HealthCall smartphone app program (Hasin et al., 2013; Hasin et al., 2014). Participants will complete a brief baseline meeting (~20 minutes) with a counselor to discuss alcohol use, liver function, and HIV medication adherence. They will track their drinking using HealthCall for 60 days, with brief follow-up meetings with their counselor to check in about their drinking 30 and 60 days later.</description>
    <arm_group_label>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 18 through 99 (inclusive)&#xD;
&#xD;
          -  HIV infection&#xD;
&#xD;
          -  Ever been diagnosed with HCV infection (regardless of treatment status; including&#xD;
             active or remitted infection)&#xD;
&#xD;
          -  Recent (last 3 month) liver panel results available&#xD;
&#xD;
          -  During prior 30 days, â‰¥4 drinks in one day at least once&#xD;
&#xD;
          -  Can speak and read English&#xD;
&#xD;
          -  Current and regular HIV care in NYC metro area&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participation in ongoing HealthCall study at Montefiore Hospital&#xD;
&#xD;
          -  Potential participant has definite plans to leave the greater New York metropolitan&#xD;
             area during study period&#xD;
&#xD;
          -  Potential participant is psychotic, suicidal, or homicidal&#xD;
&#xD;
          -  Potential participant is at-risk for developing alcohol withdrawal symptoms&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jennifer C Elliott, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York State Psychiatric Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NewYork-Presbyterian / Columbia University Medical Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.niaaa.nih.gov/guide</url>
    <description>National Institute on Alcohol Abuse and Alcoholism - Helping Patients Who Drink Too Much: A Clinician's Guide</description>
  </link>
  <reference>
    <citation>Hasin DS, Aharonovich E, Greenstein E. HealthCall for the smartphone: technology enhancement of brief intervention in HIV alcohol dependent patients. Addict Sci Clin Pract. 2014 Feb 17;9:5. doi: 10.1186/1940-0640-9-5.</citation>
    <PMID>24533631</PMID>
  </reference>
  <reference>
    <citation>Hasin DS, Aharonovich E, O'Leary A, Greenstein E, Pavlicova M, Arunajadai S, Waxman R, Wainberg M, Helzer J, Johnston B. Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement. Addiction. 2013 Jul;108(7):1230-40. doi: 10.1111/add.12127. Epub 2013 Apr 17.</citation>
    <PMID>23432593</PMID>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>August 24, 2018</study_first_submitted>
  <study_first_submitted_qc>August 28, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 29, 2018</study_first_posted>
  <results_first_submitted>June 1, 2021</results_first_submitted>
  <results_first_submitted_qc>June 29, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">July 20, 2021</results_first_posted>
  <last_update_submitted>July 21, 2021</last_update_submitted>
  <last_update_submitted_qc>July 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>New York State Psychiatric Institute</investigator_affiliation>
    <investigator_full_name>Jennifer C Elliott</investigator_full_name>
    <investigator_title>Research Scientist</investigator_title>
  </responsible_party>
  <keyword>Heavy Drinking</keyword>
  <keyword>HIV</keyword>
  <keyword>Hepatitis C</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
    <mesh_term>Alcoholism</mesh_term>
    <mesh_term>Binge Drinking</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 1, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/75/NCT03652675/Prot_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 6, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/75/NCT03652675/SAP_002.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>July 9, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/75/NCT03652675/ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</title>
          <description>Intervention: (Clinician's Guide + HealthCall for HIV/HCV): This intervention consists of an adaptation of the National Institutes of Health (NIH) Clinician's Guide (CG; NIAAA, 2007) in conjunction with the previously tested HealthCall smartphone app program (Hasin et al., 2013; Hasin et al., 2014). Participants will complete a brief baseline meeting (~20 minutes) with a counselor to discuss alcohol use, liver function, and HIV medication adherence. They will track their drinking using HealthCall for 60 days, with brief follow-up meetings with their counselor to check in about their drinking 30 and 60 days later.</description>
        </group>
        <group group_id="P2">
          <title>Educational Control Condition</title>
          <description>Participant will spend 20 minutes at the clinic, observed by the counselor, reviewing an educational pamphlet on drinking, HIV, and HCV.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="15"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="11"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</title>
          <description>Intervention: (Clinician's Guide + HealthCall for HIV/HCV): This intervention consists of an adaptation of the National Institutes of Health (NIH) Clinician's Guide (CG; NIAAA, 2007) in conjunction with the previously tested HealthCall smartphone app program (Hasin et al., 2013; Hasin et al., 2014). Participants will complete a brief baseline meeting (~20 minutes) with a counselor to discuss alcohol use, liver function, and HIV medication adherence. They will track their drinking using HealthCall for 60 days, with brief follow-up meetings with their counselor to check in about their drinking 30 and 60 days later.</description>
        </group>
        <group group_id="B2">
          <title>Educational Control Condition</title>
          <description>Participant will spend 20 minutes at the clinic, observed by the counselor, reviewing an educational pamphlet on drinking, HIV, and HCV.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="16"/>
            <count group_id="B2" value="15"/>
            <count group_id="B3" value="31"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56.7" spread="11.2"/>
                    <measurement group_id="B2" value="56.1" spread="9.7"/>
                    <measurement group_id="B3" value="56.4" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="9"/>
                    <measurement group_id="B3" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Transgender</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="25"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Baseline Drinks per Drinking Day</title>
          <units>Drinks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5.24" spread="3.8"/>
                    <measurement group_id="B2" value="6.09" spread="2.17"/>
                    <measurement group_id="B3" value="5.65" spread="3.10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Drinks Per Drinking Day Measured Using Timeline Follow Back (TLFB) at 60 Days.</title>
        <description>Mean drinks per drinking day in the last 30 days, assessed at baseline and repeatedly during follow-up so that change can be analyzed. Abstention is coded as zero.</description>
        <time_frame>60 days (end of treatment)</time_frame>
        <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
Drinks per drinking day (primary outcome), with abstention coded as zero, at 60 days (end-of-treatment)</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</title>
            <description>Intervention: (Clinician's Guide + HealthCall for HIV/HCV): This intervention consists of an adaptation of the National Institutes of Health (NIH) Clinician's Guide (CG; NIAAA, 2007) in conjunction with the previously tested HealthCall smartphone app program (Hasin et al., 2013; Hasin et al., 2014). Participants will complete a brief baseline meeting (~20 minutes) with a counselor to discuss alcohol use, liver function, and HIV medication adherence. They will track their drinking using HealthCall for 60 days, with brief follow-up meetings with their counselor to check in about their drinking 30 and 60 days later.</description>
          </group>
          <group group_id="O2">
            <title>Educational Control Condition</title>
            <description>Participant will spend 20 minutes at the clinic, observed by the counselor, reviewing an educational pamphlet on drinking, HIV, and HCV.</description>
          </group>
        </group_list>
        <measure>
          <title>Mean Drinks Per Drinking Day Measured Using Timeline Follow Back (TLFB) at 60 Days.</title>
          <description>Mean drinks per drinking day in the last 30 days, assessed at baseline and repeatedly during follow-up so that change can be analyzed. Abstention is coded as zero.</description>
          <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
Drinks per drinking day (primary outcome), with abstention coded as zero, at 60 days (end-of-treatment)</population>
          <units>Drinks per drinking day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.61" spread="3.35"/>
                    <measurement group_id="O2" value="5.49" spread="4.24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Number of Days Drank as Assessed by Item From the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS)</title>
        <description>Number of days drank in the last 30 days (RANGE 0-30) was assessed at baseline and repeatedly during follow-up so that change can be analyzed. A change value is calculated here such that a negative value indicates a decrease in drinking.</description>
        <time_frame>60 days (end of treatment)</time_frame>
        <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
Change scores from baseline - AUDADIS drinking variables at 60 days</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</title>
            <description>Intervention: (Clinician's Guide + HealthCall for HIV/HCV): This intervention consists of an adaptation of the National Institutes of Health (NIH) Clinician's Guide (CG; NIAAA, 2007) in conjunction with the previously tested HealthCall smartphone app program (Hasin et al., 2013; Hasin et al., 2014). Participants will complete a brief baseline meeting (~20 minutes) with a counselor to discuss alcohol use, liver function, and HIV medication adherence. They will track their drinking using HealthCall for 60 days, with brief follow-up meetings with their counselor to check in about their drinking 30 and 60 days later.</description>
          </group>
          <group group_id="O2">
            <title>Educational Control Condition</title>
            <description>Participant will spend 20 minutes at the clinic, observed by the counselor, reviewing an educational pamphlet on drinking, HIV, and HCV.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Number of Days Drank as Assessed by Item From the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS)</title>
          <description>Number of days drank in the last 30 days (RANGE 0-30) was assessed at baseline and repeatedly during follow-up so that change can be analyzed. A change value is calculated here such that a negative value indicates a decrease in drinking.</description>
          <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
Change scores from baseline - AUDADIS drinking variables at 60 days</population>
          <units>Days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-6.08" spread="10.75"/>
                    <measurement group_id="O2" value="-3.09" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Self-efficacy to Change Drinking as Measured by Brief Version of Situational Confidence Questionnaire (SCQ)</title>
        <description>Self-efficacy to change drinking in the last 30 days, assessed at baseline and repeatedly during follow-up so that change can be analyzed. Participants rate eight situations regarding their confidence in their ability to resist drinking (0% - Not at all confident to 100% - Totally confident). The final score is an average that can range from 0 (lowest) to 100 (highest) self-efficacy.</description>
        <time_frame>60 days (end of treatment)</time_frame>
        <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up.Two participants were missing SCQ data at 60 days, so results are reported for 21 participants.&#xD;
Self-efficacy at 60 days (end-of-treatment), as measured by brief version of Situational Confidence Questionnaire (SCQ)</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</title>
            <description>Intervention: (Clinician's Guide + HealthCall for HIV/HCV): This intervention consists of an adaptation of the National Institutes of Health (NIH) Clinician's Guide (CG; NIAAA, 2007) in conjunction with the previously tested HealthCall smartphone app program (Hasin et al., 2013; Hasin et al., 2014). Participants will complete a brief baseline meeting (~20 minutes) with a counselor to discuss alcohol use, liver function, and HIV medication adherence. They will track their drinking using HealthCall for 60 days, with brief follow-up meetings with their counselor to check in about their drinking 30 and 60 days later.</description>
          </group>
          <group group_id="O2">
            <title>Educational Control Condition</title>
            <description>Participant will spend 20 minutes at the clinic, observed by the counselor, reviewing an educational pamphlet on drinking, HIV, and HCV.</description>
          </group>
        </group_list>
        <measure>
          <title>Self-efficacy to Change Drinking as Measured by Brief Version of Situational Confidence Questionnaire (SCQ)</title>
          <description>Self-efficacy to change drinking in the last 30 days, assessed at baseline and repeatedly during follow-up so that change can be analyzed. Participants rate eight situations regarding their confidence in their ability to resist drinking (0% - Not at all confident to 100% - Totally confident). The final score is an average that can range from 0 (lowest) to 100 (highest) self-efficacy.</description>
          <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up.Two participants were missing SCQ data at 60 days, so results are reported for 21 participants.&#xD;
Self-efficacy at 60 days (end-of-treatment), as measured by brief version of Situational Confidence Questionnaire (SCQ)</population>
          <units>Points on the SCQ</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="9"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74.86" spread="17.99"/>
                    <measurement group_id="O2" value="66.3" spread="17.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Readiness to Change Drinking Measured by University of Rhode Island Change Assessment Scale (URICA)</title>
        <description>Readiness to change drinking in the last 30 days, assessed at baseline and repeatedly during follow-up so that change can be analyzed.&#xD;
Higher scores indicate more readiness to change. Range from -2 to +14.&#xD;
The scale is scored when points are averaged for all four (precontemplation, contemplation, action, maintenance) scales. Add Contemplation + Action + Maintenance averages, then subtract Precontemplation average.</description>
        <time_frame>60 days (end of treatment)</time_frame>
        <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
Readiness to change, as measured by the URICA</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</title>
            <description>Intervention: (Clinician's Guide + HealthCall for HIV/HCV): This intervention consists of an adaptation of the National Institutes of Health (NIH) Clinician's Guide (CG; NIAAA, 2007) in conjunction with the previously tested HealthCall smartphone app program (Hasin et al., 2013; Hasin et al., 2014). Participants will complete a brief baseline meeting (~20 minutes) with a counselor to discuss alcohol use, liver function, and HIV medication adherence. They will track their drinking using HealthCall for 60 days, with brief follow-up meetings with their counselor to check in about their drinking 30 and 60 days later.</description>
          </group>
          <group group_id="O2">
            <title>Educational Control Condition</title>
            <description>Participant will spend 20 minutes at the clinic, observed by the counselor, reviewing an educational pamphlet on drinking, HIV, and HCV.</description>
          </group>
        </group_list>
        <measure>
          <title>Readiness to Change Drinking Measured by University of Rhode Island Change Assessment Scale (URICA)</title>
          <description>Readiness to change drinking in the last 30 days, assessed at baseline and repeatedly during follow-up so that change can be analyzed.&#xD;
Higher scores indicate more readiness to change. Range from -2 to +14.&#xD;
The scale is scored when points are averaged for all four (precontemplation, contemplation, action, maintenance) scales. Add Contemplation + Action + Maintenance averages, then subtract Precontemplation average.</description>
          <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
Readiness to change, as measured by the URICA</population>
          <units>Points on the URICA</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.82" spread="2.16"/>
                    <measurement group_id="O2" value="8.98" spread="1.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Readiness to Change Drinking Measured by The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES)</title>
        <description>Readiness to change drinking in the last 30 days,assessed at baseline and repeatedly during follow-up so that change can be analyzed.&#xD;
Higher scores indicate more recognition, ambivalence, and taking steps toward change, respectively. For full range and interpretation, see individual outcomes below.&#xD;
Recognition scale - Range 7 (very low recognition) to 35 (high recognition)&#xD;
Ambivalence scale - Range 4 (very low ambivalence) to 20 (very high ambivalence)&#xD;
Taking Steps scale - Range 8 (very low on taking steps to change drinking) to 40 (very high score)</description>
        <time_frame>60 days (end of treatment)</time_frame>
        <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
SOCRATES subscales - Recognition, Ambivalence, Taking Steps</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</title>
            <description>Intervention: (Clinician's Guide + HealthCall for HIV/HCV): This intervention consists of an adaptation of the National Institutes of Health (NIH) Clinician's Guide (CG; NIAAA, 2007) in conjunction with the previously tested HealthCall smartphone app program (Hasin et al., 2013; Hasin et al., 2014). Participants will complete a brief baseline meeting (~20 minutes) with a counselor to discuss alcohol use, liver function, and HIV medication adherence. They will track their drinking using HealthCall for 60 days, with brief follow-up meetings with their counselor to check in about their drinking 30 and 60 days later.</description>
          </group>
          <group group_id="O2">
            <title>Educational Control Condition</title>
            <description>Participant will spend 20 minutes at the clinic, observed by the counselor, reviewing an educational pamphlet on drinking, HIV, and HCV.</description>
          </group>
        </group_list>
        <measure>
          <title>Readiness to Change Drinking Measured by The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES)</title>
          <description>Readiness to change drinking in the last 30 days,assessed at baseline and repeatedly during follow-up so that change can be analyzed.&#xD;
Higher scores indicate more recognition, ambivalence, and taking steps toward change, respectively. For full range and interpretation, see individual outcomes below.&#xD;
Recognition scale - Range 7 (very low recognition) to 35 (high recognition)&#xD;
Ambivalence scale - Range 4 (very low ambivalence) to 20 (very high ambivalence)&#xD;
Taking Steps scale - Range 8 (very low on taking steps to change drinking) to 40 (very high score)</description>
          <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
SOCRATES subscales - Recognition, Ambivalence, Taking Steps</population>
          <units>Points on the SOCRATES subscales</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Recognition scale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="26.08" spread="6.4"/>
                    <measurement group_id="O2" value="26.55" spread="3.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Ambivalence scale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12.25" spread="2.99"/>
                    <measurement group_id="O2" value="13.36" spread="2.98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Taking Steps scale</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="34.33" spread="4.79"/>
                    <measurement group_id="O2" value="28.73" spread="6.42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Largest Number of Drinks Assessed by Item From the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS)</title>
        <description>The largest number of drinks consumed within one day in the last 30 days (RANGE 0-30) was assessed at baseline and repeatedly during follow-up so that change can be analyzed. A change value is calculated here such that a negative value indicates a decrease in drinking.</description>
        <time_frame>60 days (end of treatment)</time_frame>
        <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
Change scores from baseline - AUDADIS drinking variables at 60 days</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</title>
            <description>Intervention: (Clinician's Guide + HealthCall for HIV/HCV): This intervention consists of an adaptation of the National Institutes of Health (NIH) Clinician's Guide (CG; NIAAA, 2007) in conjunction with the previously tested HealthCall smartphone app program (Hasin et al., 2013; Hasin et al., 2014). Participants will complete a brief baseline meeting (~20 minutes) with a counselor to discuss alcohol use, liver function, and HIV medication adherence. They will track their drinking using HealthCall for 60 days, with brief follow-up meetings with their counselor to check in about their drinking 30 and 60 days later.</description>
          </group>
          <group group_id="O2">
            <title>Educational Control Condition</title>
            <description>Participant will spend 20 minutes at the clinic, observed by the counselor, reviewing an educational pamphlet on drinking, HIV, and HCV.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Largest Number of Drinks Assessed by Item From the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS)</title>
          <description>The largest number of drinks consumed within one day in the last 30 days (RANGE 0-30) was assessed at baseline and repeatedly during follow-up so that change can be analyzed. A change value is calculated here such that a negative value indicates a decrease in drinking.</description>
          <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
Change scores from baseline - AUDADIS drinking variables at 60 days</population>
          <units>drinks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-4" spread="5.15"/>
                    <measurement group_id="O2" value="-5.36" spread="9.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Number of Days Binge Drinking as Assessed by Item From the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS)</title>
        <description>Number of days engaging in binge drinking (4+ drinks) in the last 30 days (RANGE 0-30) was assessed at baseline and repeatedly during follow-up so that change can be analyzed. A change value is calculated here such that a negative value indicates a decrease in drinking.</description>
        <time_frame>60 days (end of treatment)</time_frame>
        <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
Change scores from baseline - AUDADIS drinking variables at 60 days</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</title>
            <description>Intervention: (Clinician's Guide + HealthCall for HIV/HCV): This intervention consists of an adaptation of the National Institutes of Health (NIH) Clinician's Guide (CG; NIAAA, 2007) in conjunction with the previously tested HealthCall smartphone app program (Hasin et al., 2013; Hasin et al., 2014). Participants will complete a brief baseline meeting (~20 minutes) with a counselor to discuss alcohol use, liver function, and HIV medication adherence. They will track their drinking using HealthCall for 60 days, with brief follow-up meetings with their counselor to check in about their drinking 30 and 60 days later.</description>
          </group>
          <group group_id="O2">
            <title>Educational Control Condition</title>
            <description>Participant will spend 20 minutes at the clinic, observed by the counselor, reviewing an educational pamphlet on drinking, HIV, and HCV.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Number of Days Binge Drinking as Assessed by Item From the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS)</title>
          <description>Number of days engaging in binge drinking (4+ drinks) in the last 30 days (RANGE 0-30) was assessed at baseline and repeatedly during follow-up so that change can be analyzed. A change value is calculated here such that a negative value indicates a decrease in drinking.</description>
          <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
Change scores from baseline - AUDADIS drinking variables at 60 days</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-7.92" spread="8.24"/>
                    <measurement group_id="O2" value="-6.27" spread="11.66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Number of Days Intoxicated as Assessed by Item From the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS)</title>
        <description>Number of days intoxicated in the last 30 days (RANGE 0-30) was assessed at baseline and repeatedly during follow-up so that change can be analyzed. A change value is calculated here such that a negative value indicates a decrease in drinking.</description>
        <time_frame>60 days (end of treatment)</time_frame>
        <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
Change scores from baseline - AUDADIS drinking variables at 60 days</population>
        <group_list>
          <group group_id="O1">
            <title>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</title>
            <description>Intervention: (Clinician's Guide + HealthCall for HIV/HCV): This intervention consists of an adaptation of the National Institutes of Health (NIH) Clinician's Guide (CG; NIAAA, 2007) in conjunction with the previously tested HealthCall smartphone app program (Hasin et al., 2013; Hasin et al., 2014). Participants will complete a brief baseline meeting (~20 minutes) with a counselor to discuss alcohol use, liver function, and HIV medication adherence. They will track their drinking using HealthCall for 60 days, with brief follow-up meetings with their counselor to check in about their drinking 30 and 60 days later.</description>
          </group>
          <group group_id="O2">
            <title>Educational Control Condition</title>
            <description>Participant will spend 20 minutes at the clinic, observed by the counselor, reviewing an educational pamphlet on drinking, HIV, and HCV.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Number of Days Intoxicated as Assessed by Item From the Alcohol Use Disorder and Associated Disabilities Interview Schedule (AUDADIS)</title>
          <description>Number of days intoxicated in the last 30 days (RANGE 0-30) was assessed at baseline and repeatedly during follow-up so that change can be analyzed. A change value is calculated here such that a negative value indicates a decrease in drinking.</description>
          <population>Of the 31 participants enrolled at baseline, 23 completed the 60-day follow-up and are reported here.&#xD;
Change scores from baseline - AUDADIS drinking variables at 60 days</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="11"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.83" spread="4.13"/>
                    <measurement group_id="O2" value="-0.64" spread="6.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Every 30 days for 90 days.</time_frame>
      <desc>Consistent with ClinicalTrials.gov definition.</desc>
      <group_list>
        <group group_id="E1">
          <title>Intervention: (Clinician's Guide + HealthCall for HIV/HCV)</title>
          <description>Intervention: (Clinician's Guide + HealthCall for HIV/HCV): This intervention consists of an adaptation of the National Institutes of Health (NIH) Clinician's Guide (CG; NIAAA, 2007) in conjunction with the previously tested HealthCall smartphone app program (Hasin et al., 2013; Hasin et al., 2014). Participants will complete a brief baseline meeting (~20 minutes) with a counselor to discuss alcohol use, liver function, and HIV medication adherence. They will track their drinking using HealthCall for 60 days, with brief follow-up meetings with their counselor to check in about their drinking 30 and 60 days later.</description>
        </group>
        <group group_id="E2">
          <title>Educational Control Condition</title>
          <description>Participant will spend 20 minutes at the clinic, observed by the counselor, reviewing an educational pamphlet on drinking, HIV, and HCV.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="16"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="15"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>As recruitment started later and moved more slowly than intended, a smaller sample size than intended was obtained.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Jennifer C Elliott, PhD</name_or_title>
      <organization>Columbia University / New York State Psychiatric Institute</organization>
      <phone>646 774 7953</phone>
      <email>jce2130@cumc.columbia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

